Hemogenyx Pharmaceuticals (HEMO) announced that it has submitted its Annual Report to the FDA under the active Investigational New Drug (IND) application for HG-CT-1, the Company’s proprietary CAR-T cell therapy for
Share Talk Weekly Stock Market News Review, Sunday 23rd March 2025
Growth stock investors had reason to be cheerful: The AIM All-Share climbed 1.2% over the week to 694.97, outperforming the FTSE 100—even as market nerves in the US sent ripples
RNS Hotlist with Zak Mir: PRD, GSCU, OBI, BKS, HEMO & EML
Predator Oil & Gas (PRD), the Jersey-based Oil and Gas Company with near-term hydrocarbon operations and production focussed on Morocco and Trinidad, announced an update on the preliminary MOU-5 drilling results
Share Talk Weekly Stock Market News Review, Sunday 16th March 2025
Investors shrugged off pessimism at the close of play on Friday. The FTSE 100 climbed by 1.1%, while the UK-centric FTSE 250 advanced by 1.6%. Gold reached a record high
RNS Hotlist with Zak Mir: EAAS, TERN, PSN, EEE, ZPHR, CHLL, APTA, ZEN, EME, HEMO & SOLI
eEnergy Group (EAAS), a provider of energy efficiency solutions, announce three contract wins across the NHS and education sectors. EAAS said “Significantly, these contracts are outside our traditional routes to market,
Share Talk Weekly Stock Market News Review, Sunday 2nd March 2025
The FTSE 100 climbed 0.6%, closing at 8,809.74, just 11 points shy of its all-time high earlier this month.
Hemogenyx Pharma Plc (LON:HEMO) First-in-Human leukaemia treatment with HG-CT-1
First-in-Human Treatment with HG-CT-1 for Relapsed or Refractory Acute Myeloid Leukemia
RNS Hotlist with Zak Mir: EPP, CLA, SCGL, LIFS, HEMO, TM1, GSK & BOR
(Alliance News) – Keir Starmer is expected to join world leaders in a call hosted by Ukrainian President Volodymyr Zelensky to mark the third anniversary of Russia’s invasion as the UK
Share Talk Weekly Stock Market News Review, Sunday 5th January 2025
On Friday, gold continued its upward momentum, bolstering a robust start to the year. By late morning, the precious metal was priced at US$2,657 per ounce, reflecting a daily increase
Hemogenyx Pharma Plc (LON:HEMO) announced a “major milestone” by launching its first trial site
Hemogenyx Pharmaceuticals PLC (LSE: HEMO, OTC: HOPHF) announced a “major milestone” by launching its first trial site and beginning patient recruitment for the clinical trial of its flagship drug, which
RNS Hotlist with Zak Mir: MSMN, SALT, INSG, HEMO, HARL, CRTM, KAV & ZEN
Mosman Oil and Gas (MSMN) the helium, hydrogen and hydrocarbon exploration, development and production company, announced that it has secured Tribal Council approval from the Ute Mountain Ute Tribe to lease
Hemogenyx Pharma Plc (LON:HEMO) Ultrafast CAR-T Manufacturing
Hemogenyx Pharmaceuticals PLC (LSE: HEMO, OTC: HOPHF), a UK-listed biopharmaceutical company specializing in blood cancer treatments, has partnered with Kure.ai to develop an ultrafast manufacturing process for its CAR-T cell